HTBX Stock Price, News & Analysis
Company Description
HTBX (NYSE: HTBX) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $72.6M.
HTBX stock has declined 66.9% over the past year.
This page provides a comprehensive overview of HTBX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
HTBX (HTBX) stock. Over the past 12 months, the stock has lost 66.9%. At a market capitalization of $72.6M, HTBX is classified as a micro-cap stock with approximately 25.6M shares outstanding.
Latest News
HTBX has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, conferences, acquisition. View all HTBX news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
HTBX Company Profile & Sector Positioning
HTBX (HTBX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NYSE.
Investors comparing HTBX often look at related companies in the same sector, including CIBUS INC (CBUS), Alterity Therapeutics Ltd (ATHE), Aligos Therapeutics, Inc. (ALGS), Beyondspring Inc (BYSI), and Context Therapeutics Inc (CNTX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate HTBX's relative position within its industry.